Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 13/20 | 0.61 |
| ▸ | GRIK2 | Q13002 | 13/20 | 0.61 |
| ▸ | CPA1 | P15085 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.31 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6050002 | 0.83 | GRIK1 (0.75) | GRIK1GRIK2CPA1CYP2C19SLC1A1 | |
| SCHEMBL6449828 | 0.77 | — | — | |
| SCHEMBL891727 | 0.76 | GRIK1 (0.64) | GRIK1GRIK2CPA1CYP2C19 | |
| SCHEMBL15312401 | 0.76 | GRIK1 (1.00) | GRIK1GRIK2SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL7751545 | 0.76 | GRIK1 (1.00) | GRIK1GRIK2SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL594101 | 0.76 | GRIK1 (1.00) | GRIK1GRIK2SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL594100 | 0.76 | GRIK1 (1.00) | GRIK1GRIK2SLC1A1SLC1A3SLC1A2 | |
| Hydrochloric Acid SCHEMBL9087042 | 0.74 | GRIK1 (0.96) | GRIK1GRIK2SLC1A1SLC1A3SLC1A2 | |
| Hydrochloric Acid SCHEMBL9087046 | 0.74 | GRIK1 (0.96) | GRIK1GRIK2SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL174976 | 0.74 | GRIK1 (0.50) | GRIK1GRIK2CPA1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5990166-A | O-(1-CARBOXYOCTYLCARBONYLAMINO)PHENOL AS A CARRIER; DRUG DELIVERY; ACID RESISTANCE; FORMING NONCOVALENT MIXTURES WITH BIOLOGICALLY ACTIVE AGENTS FOR ORAL ADMINISTRATION; E.G., CALCITONIN, INSULIN, POLYSACCHARIDES, MUCOPOLYSACCHARIDES | EMISPHERE TECHNOLOGIES, INC. (US) | 1999-11-23 | — | — | US | disclosed |